Non-invasive Prenatal Testing (NIPT) Market, By Test Type (Panel 1 Test, Panel 2 Test, Panel 3 Test), By End User (Hospitals, Diagnostic Laboratories, Maternity Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Afr

Non-invasive Prenatal Testing (NIPT) Market, By Test Type (Panel 1 Test, Panel 2 Test, Panel 3 Test), By End User (Hospitals, Diagnostic Laboratories, Maternity Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Non-invasive prenatal testing (NIPT) is a DNA test on maternal blood to screen pregnancies for the most common fetal chromosome anomalies such as trisomy 21 that is Down syndrome, trisomy 18 Edwards syndrome and trisomy 13 Patau syndrome. During non-invasive prenatal testing DNA from the mother and fetus is extracted from maternal blood sample and it is recommended for women who have risk factors for having a baby who has a chromosomal condition. Increasing launches and approvals of new non-invasive prenatal tests (NIPT) along with increasing prevalence of chromosomal disorders is expected to propel the market growth during the forecasted period.
Key features of the study:
This report provides in-depth analysis of the Global Non-Invasive Prenatal Testing market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the Global Non-Invasive Prenatal Testing market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Ariosa Diagnostics, Inc., BGI Diagnosis Co., Ltd., Berry Genomics Corporation, Illumina, Inc., LifeCodexx AG, Natera, Inc., Sequenom, Inc., Natera, Inc., Axia Women’s Health, Eluthia, BillionToOne, Inc., and Quest Diagnostics Incorporated
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The Global Non-Invasive Prenatal Testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Non-Invasive Prenatal Testing market
Detailed Segmentation:
Global Non-Invasive Prenatal Testing Market, By Test Type:
Panel 1 Test
Panel 2 Test
Panel 3 Test
Global Non-Invasive Prenatal Testing Market, By End User:
Hospitals
Diagnostic Laboratories
Maternity Centers
Global Non-Invasive Prenatal Testing Market, By Region:
North America
By Test Type:
Panel 1 Test
Panel 2 Test
Panel 3 Test
By End User
Hospitals
Diagnostic Laboratories
Maternity Centers
By Country
U.S.
Canada
Latin America
By Test Type:
Panel 1 Test
Panel 2 Test
Panel 3 Test
By End User
Hospitals
Diagnostic Laboratories
Maternity Centers
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Test Type:
Panel 1 Test
Panel 2 Test
Panel 3 Test
By End User
Hospitals
Diagnostic Laboratories
Maternity Centers
By Country
U.K.
Germany
France
Spain
Italy
Russia
Rest of Europe
Asia Pacific
By Test Type:
Panel 1 Test
Panel 2 Test
Panel 3 Test
By End User
Hospitals
Diagnostic Laboratories
Maternity Centers
By Country
China
Japan
India
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Test Type:
Panel 1 Test
Panel 2 Test
Panel 3 Test
By End User
Hospitals
Diagnostic Laboratories
Maternity Centers
By Country
GCC Countries
Israel
Rest of Middle East
Africa
By Test Type:
Panel 1 Test
Panel 2 Test
Panel 3 Test
By End User
Hospitals
Diagnostic Laboratories
Maternity Centers
By Country
North Africa
Central Africa
South Africa
Company Profiles
Ariosa Diagnostics, Inc. *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
BGI Diagnosis Co., ltd.
Berry Genomics Corporation
Illumina, Inc.
LifeCodexx AG
Natera, Inc.
Sequenom, Inc.
Natera, Inc.
Axia Women’s Health
Eluthia
BillionToOne, Inc.
Quest Diagnostics Incorporated
“*” marked represents similar segmentation in other categories in the respective section.